Behind the scenes with TissueCypher Barrett's Esophagus:

Get to know the technology driving better BE risk stratification

The recorded webinar below features Rebecca Critchley-Thorne, Ph.D,  VP of R&D, Spatialomics & GI,  at Castle Biosciences, speaking about the development of TissueCypher as well as its clinical validation and utility studies. Following her presentation was a live Q&A session addressing questions from the audience